Annovis Bio's Cash And Cash Equivalents Totaled $3.1M As Of March 31, 2024, Will Fund Its Operations Into The Fourth Quarter Of 2024
Annovis Bio's Cash And Cash Equivalents Totaled $3.1M As Of March 31, 2024, Will Fund Its Operations Into The Fourth Quarter Of 2024
截至2024年3月31日，Annovis Bio的現金和現金等價物總額爲310萬美元，將爲2024年第四季度的運營提供資金
Annovis Bio's Cash And Cash Equivalents Totaled $3.1M As Of March 31, 2024, Will Fund Its Operations Into The Fourth Quarter Of 2024
截至2024年3月31日，Annovis Bio的現金和現金等價物總額爲310萬美元，將爲2024年第四季度的運營提供資金
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。